Possible Efficacy Related Differences Among Cannabinoid Agonists

MLA

Jack Bergman, et al. “Possible Efficacy Related Differences Among Cannabinoid Agonists.” The FASEB Journal, vol. 27, Apr. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........24dd501a17e5e63a56a8732abc6a7e6e&authtype=sso&custid=ns315887.

APA

Jack Bergman, Girish Chopda, Kiran Vemuri, Alexandros Makriyannis, & Carol A. Paronis. (2013). Possible Efficacy Related Differences Among Cannabinoid Agonists. The FASEB Journal, 27.

Chicago

Jack Bergman, Girish Chopda, Kiran Vemuri, Alexandros Makriyannis, and Carol A. Paronis. 2013. “Possible Efficacy Related Differences Among Cannabinoid Agonists.” The FASEB Journal 27 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........24dd501a17e5e63a56a8732abc6a7e6e&authtype=sso&custid=ns315887.